BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15315341)

  • 1. Effects of the combined use of benazepril and valsartan on apoptosis in the kidney of rats with adriamycin-induced nephritic glomerulosclerosis.
    Han Z; Xing Y; Wang H; Liang X; Zhou J
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(3):254-8. PubMed ID: 15315341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of benazepril on apoptosis in the kidney of diabetic rats].
    Duan HJ; Zhang YL; Shi YH; Liu F; Li YM
    Yao Xue Xue Bao; 2002 Jun; 37(6):409-11. PubMed ID: 12579793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, randomized, double-blind, noninferiority study.
    Lee IT; Hung YJ; Chen JF; Wang CY; Lee WJ; Sheu WH
    Clin Ther; 2012 Aug; 34(8):1735-50. PubMed ID: 22784975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of benazepril combined with valsartan on congestive heart failure].
    Ye JF; Liu DS
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Nov; 25(11):1441-2, 1447. PubMed ID: 16305977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade.
    Barker TA; Massett MP; Korshunov VA; Mohan AM; Kennedy AJ; Berk BC
    Hypertension; 2006 Nov; 48(5):942-9. PubMed ID: 16982965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
    Stergiou GS; Makris T; Papavasiliou M; Efstathiou S; Manolis A
    J Hypertens; 2005 Apr; 23(4):883-9. PubMed ID: 15775795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combined ACE inhibitor and angiotensin II antagonist treatment in human chronic nephropathies.
    Campbell R; Sangalli F; Perticucci E; Aros C; Viscarra C; Perna A; Remuzzi A; Bertocchi F; Fagiani L; Remuzzi G; Ruggenenti P
    Kidney Int; 2003 Mar; 63(3):1094-103. PubMed ID: 12631093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of add-on fluvastatin therapy in patients with chronic proteinuric nephropathy on dual renin-angiotensin system blockade: the ESPLANADE trial.
    Ruggenenti P; Perna A; Tonelli M; Loriga G; Motterlini N; Rubis N; Ledda F; Rota S; Satta A; Granata A; Battaglia G; Cambareri F; David S; Gaspari F; Stucchi N; Carminati S; Ene-Iordache B; Cravedi P; Remuzzi G;
    Clin J Am Soc Nephrol; 2010 Nov; 5(11):1928-38. PubMed ID: 20671225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiatherogenic effect of angiotensin converting enzyme inhibitor (benazepril) and angiotensin II receptor antagonist (valsartan) in the cholesterol-fed rabbits.
    Li J; Hirose N; Kawamura M; Arai Y
    Atherosclerosis; 1999 Apr; 143(2):315-26. PubMed ID: 10217360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1.
    Ma LJ; Nakamura S; Aldigier JC; Rossini M; Yang H; Liang X; Nakamura I; Marcantoni C; Fogo AB
    J Am Soc Nephrol; 2005 Apr; 16(4):966-76. PubMed ID: 15728787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Ke YS; Cao H; Yang T
    Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake.
    Weir MR; Smith DH; Neutel JM; Bedigian MP
    Am J Hypertens; 2001 Jul; 14(7 Pt 1):665-71. PubMed ID: 11465651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of angiotensin converting enzyme but not of angiotensin AT1 receptors improves glucose tolerance.
    Chow L; De Gasparo M; Levens N
    Eur J Pharmacol; 1997 Jan; 319(1):77-83. PubMed ID: 9030901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy.
    Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU
    Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB mediates Kupffer cell apoptosis through transcriptional activation of Fas/FasL.
    Peng Y; Gallagher SF; Haines K; Baksh K; Murr MM
    J Surg Res; 2006 Jan; 130(1):58-65. PubMed ID: 16154149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats.
    Toblli JE; DeRosa G; Cao G; Piorno P; Pagano P
    Kidney Int; 2004 Jun; 65(6):2343-59. PubMed ID: 15149348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination is better than monotherapy with ACE inhibitor or angiotensin receptor antagonist at recommended doses.
    Segura J; Praga M; Campo C; Rodicio JL; Ruilope LM
    J Renin Angiotensin Aldosterone Syst; 2003 Mar; 4(1):43-7. PubMed ID: 12692753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of blocking renin-angiotensin system on the progression of renal injury in glomerulosclerosis.
    Ji Z; Huang C; Liang C; Chen B; Chen S; Sun W
    Cell Mol Immunol; 2005 Apr; 2(2):150-4. PubMed ID: 16191423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of RAS inhibition in the regulation of Cu/Zn-SOD in the cardiac and peripheral arterial beds in humans.
    Kuster GM; Nietlispach F; Kiowski W; Schindler R; Bernheim A; Schuetz P; Mueller B; Morgenthaler NG; RĂ¼ter F; Riesen W; Rickli H; Brunner-La Rocca HP
    Clin Pharmacol Ther; 2010 Jun; 87(6):686-92. PubMed ID: 20445533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.